Suchergebnisse - "Ader, Florence"

PubPharm (256)

21

Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial

enthalten in: Critical care | 2023

von Trøseid, M. | Arribas, J. | Assoumou, L. | +53

22

Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial

enthalten in: Critical care | 2023

von Trøseid, M. | Arribas, J. | Assoumou, L. | +53

23

Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency : open label, randomised clinical trial

enthalten in: BMJ medicine | 2023

von Lacombe, K. | Hueso, T. | Porcher, R. | +30

24

Hyper-inflammatory profile and immunoparalysis in patients with severe Legionnaires' disease

enthalten in: Frontiers in cellular and infection microbiology | 2023

von Allam, C. | Mouton, W. | Testaert, H. | +20

25

Implementation of a centralized pharmacovigilance system in academic pan‐European clinical trials : Experience from EU‐Response and conect4children consortia

enthalten in: British Journal of Clinical Pharmacology | 2023

von Terzić, V. | Levoyer, L. | Figarella, M. | +24

26

Management of pharmacovigilance during the COVID‐19 pandemic crisis by the safety department of an academic sponsor : Lessons learnt and challenges from the EU DisCoVeRy clinical trial

enthalten in: Pharmacology Research & Perspectives | 2023

von Mercier, N. | Belhadi, D. | DeChanet, A. | +21

27

Association between SARS‐CoV‐2 viral kinetics and clinical score evolution in hospitalized patients

enthalten in: CPT: Pharmacometrics & Systems Pharmacology | 2023

von Néant, N. | Lingas, G. | Gaymard, A. | +16

28

Effect of Swine Glyco-humanized Polyclonal Neutralizing Antibody on Survival and Respiratory Failure in Patients Hospitalized With Severe COVID-19 : A Randomized, Placebo-Controlled Trial

enthalten in: Open forum infectious diseases | 2023

von Gaborit, B. | Vanhove, B. | Lacombe, K. | +116

29

Pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal anti-SARS-CoV-2 antibody, for COVID-19-related moderate pneumonia: a randomized, double-blind, placebo-controlled, phase IIa study

enthalten in: bioRxiv.org | 2022

von Gaborit, B. | Dailly, E. | Vanhove, B. | +16

30

Impact of COVID-19 pandemic on antifungal consumption : a multicenter retrospective analysis

enthalten in: Critical care (London, England) | 2022

von Bienvenu, A. | Bestion, A. | Pradat, P. | +26